NPHLA Tracker · Compounding regulatory tracker (Federal Register / FDA)
Compounding Regulatory Tracker
Official federal records on drug compounding — Federal Register rules, proposed rules and notices, FDA announcements and safety alerts, and FDA enforcement-report recalls — tagged to 503A, 503B, GLP-1 compounding, USP standards, peptides and enforcement.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
- Records
- 54
- Changed in 7 days
- 2
- Latest record
- Jurisdiction
- United States (federal)
Records
2 changed in the last 7 days| Record | Status | Record type | Jurisdiction | Date | Source | Last checked |
|---|---|---|---|---|---|---|
| G. L. Mezzetta Inc. Announces Recall of Mezzetta Brand Golden Greek Peperoncini (Medium Heat) Due to Presence of Pest Contaminant in the JarChanged in the last 7 days Recall published in the FDA Enforcement Report · For generations, families have trusted Mezzetta products on their tables. We take that trust seriously, which is why we want to share what we know about a voluntary recall involving a specific lot of Mezzetta GOLDEN GREEK PEPERONCINI MEDIU… | Recall | Recall | United States (federal) | Enforcement report date | U.S. Food and Drug Administration: G. L. Mezzetta Inc. Announces Recall of Mezzetta Brand Golden Greek Peperoncini (Medium Heat) Due to Presence of Pest Contaminant in the Jar (opens in a new tab)Official record | System checked NPHLA updated |
| Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic CathetersChanged in the last 7 days Safety alert published · Boston Scientific Imager II Angiographic Catheters removed due to a manufacturing issue leading to tip detachment; could result in procedural delays, embolism | Safety alert | Safety alert | United States (federal) | Published | U.S. Food and Drug Administration (MedWatch): Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters (opens in a new tab)Official record | System checked NPHLA updated |
How is this tracker compiled?
The Intelligence pipeline collects official records from the Federal Register API (including a dedicated FDA compounding search), FDA press announcements, MedWatch safety alerts and recall feeds, and openFDA enforcement reports (including a search for recalls of compounded drugs). Each record is classified against the knowledge graph by matching topic names and keywords in its title and summary.
This tracker lists records from primary sources tagged with a compounding topic. News and trade-press items are excluded.
Selection: Official records (final rule, proposed rule, notice, recall, press release and safety alert) from primary sources tagged “503a”, “503b”, “glp1-compounding”, “usp-compounding”, “peptides” and “compounding-enforcement” in the NPHLA knowledge graph.
What does it cover?
U.S. federal records (FDA and the Federal Register) published since tracking of each source began. State board actions and documents FDA publishes only on its website, such as warning letters, are not yet included.
What are its limitations?
Classification is automatic and keyword-based: a record can be missed if it does not use the tracked terms, and a record can occasionally be tagged to a topic it mentions only in passing. Recall records name the firms involved exactly as FDA publishes them. Not legal advice — read the official document.
How often is it updated?
Sources are checked every 1 to 6 hours depending on the source, as configured in the Source Registry.
System checked is the last time an automated check of the underlying official sources succeeded — it is not a human review. Editorially reviewed appears only when an editor has reviewed this tracker. Each row shows its own check: an automated system check or an editor’s verification.
Data origin: NPHLA analysis of public data. Professional reference only — not medical, legal or regulatory advice. Always confirm a record in its primary source. Spotted an error? Tell us.